Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Corden Pharma Bergamo S.p.A.
03 1Honour Lab Limited
04 1Professional Compounding Centers of America dba PCCA
05 1R.L.Fine Chem Private Limited
06 1Shenzhen Oriental Pharmaceutical Co. Ltd
07 1Sigma-Aldrich Ireland Ltd.
08 1Spectrum Laboratory Products, Inc.
09 1Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni
01 2DOXYLAMINE SUCCINATE
02 6Doxylamine Succinate
03 1Doxymaine Succinate
01 1China
02 3India
03 1Italy
04 1Spain
05 2U.S.A
06 1United Kingdom
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
NDC Package Code : 57218-952
Start Marketing Date : 2022-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49964-0101
Start Marketing Date : 2009-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0070
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0034
Start Marketing Date : 2019-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71554-007
Start Marketing Date : 2019-04-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64431-0003
Start Marketing Date : 2015-08-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54154-002
Start Marketing Date : 1987-04-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2695
Start Marketing Date : 1991-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49711-0114
Start Marketing Date : 2009-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Doxylamine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxylamine Succinate, including repackagers and relabelers. The FDA regulates Doxylamine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxylamine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxylamine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxylamine Succinate supplier is an individual or a company that provides Doxylamine Succinate active pharmaceutical ingredient (API) or Doxylamine Succinate finished formulations upon request. The Doxylamine Succinate suppliers may include Doxylamine Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Doxylamine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxylamine Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxylamine Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxylamine Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxylamine Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxylamine Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxylamine Succinate suppliers with NDC on PharmaCompass.
We have 9 companies offering Doxylamine Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
